Bellerophon Therapeutics LLC (NASDAQ: BLPH)is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Its mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. For more information, visit the company’s website at www.bellerophon.com.